Drug Shortage Report for MAXALT RPD
| Report ID | 137105 |
| Drug Identification Number | 02240518 |
| Brand name | MAXALT RPD |
| Common or Proper name | rizatriptan benzoate wafers |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RIZATRIPTAN |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL ORAL |
| Packaging size | 12 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2021-06-04 |
| Actual start date | |
| Estimated end date | 2021-07-16 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2021-04-07 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-04-07 | English | Compare |
| v2 | 2021-04-07 | French | Compare |